Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

RTTNews | 377 days ago
Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

(RTTNews) - Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

The nearly 300,000-square-foot facility will employ 400 full-time staff. It also features open workspaces to foster collaboration and has been designed to meet the highest environmental sustainability standards, in support of Amgen's commitment to achieve carbon neutrality for all operations by 2027.

In partnership with Columbus State Community College, Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site. This program, designed for those new to the field or changing careers, offers a blend of classroom and practical training, aiming to expand opportunities for skilled individuals without the requirement for a formal bachelor's degree.

read more
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...
RTTNews | 283 days ago
Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
RTTNews | 929 days ago
Australian Market Maintains Early Gains In Mid-market

Australian Market Maintains Early Gains In Mid-market

The Australian stock market is maintaining its early gains in mid-market trading on Monday, reversing some of the losses in the previous four sessions, following the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is moving up to well above the 7,950.00 level, with gains across most sectors led by iron ore miners and energy stocks.
RTTNews | 4h 9min ago
Sensex, Nifty To Open On Muted Note

Sensex, Nifty To Open On Muted Note

Indian shares look set to open on a flat note Monday after Federal Reserve Chair Jerome Powell said the U.S. central bank is "well positioned to wait for greater clarity" about the impact of President Trump's policy changes.
RTTNews | 4h 21min ago
Additional Support Anticipated For Thai Stock Market

Additional Support Anticipated For Thai Stock Market

The Thai stock market has alternated between positive and negative finishes through the last five trading days since the end of the two-day slide in which it had tumbled almost 40 points or 3.2 percent. The Stock Exchange of Thailand now sits just above the 1,200-point plateau and it may add to its winnings on Monday.
RTTNews | 4h 57min ago
Win Streak May Continue For Indonesia Stock Market

Win Streak May Continue For Indonesia Stock Market

The Indonesia stock market has finished higher in three straight sessions, improving more than 350 points or 5.4 percent along the way. The Jakarta Composite Index now sits just above the 6,635-point plateau and it may extend its gains on Monday.
RTTNews | 5h 27min ago